Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
VCNXVaccinex, Inc.
| Figure | VCNXVaccinex, Inc.FY2024 · Dec |
|---|---|
| Revenue | $601.00K |
| Revenue, yoy | +5.4% |
| Net income | $18.63M |
| Net income, yoy | +8.0% |
| Net margin | -3,100.5% |
| Free cash flow | $16.21M |
| FCF margin | -2,696.8% |
| EPS, diluted | $8.88 |
Add another company.
Annual · FY2020–FY2024 · USD
From SEC EDGARSame fiscal periods, as filed